Skip to main content
Equibles

WELLINGTON MANAGEMENT GROUP LLP

Position in AKBA — Akebia Therapeutics, Inc.

CIK 902219 Boston, MA
Back to AKBA Full portfolio

Position in AKBA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$194,888
-$788,876 QoQ
Shares Held
170,955
-75.8% QoQ
Ownership
0.062%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#54
of 170 holders
Holding Since
Mar 2020
16 quarters on record
Voting authority Sole 0% Shared 68% None 32%

Common Shares in AKBA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

WELLINGTON MANAGEMENT GROUP LLP holds $2,155,261,599 across 33 Drug Manufacturers - Specialty & Generic names. AKBA ranks #33 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 UTHR
UNITED THERAPEUTICS Corp
 1,379,025 $747,197,111
2 ZTS
Zoetis Inc.
 9,423,895 $677,201,094
3 TEVA
Teva Pharmaceutical Industries Ltd
 7,671,157 $259,898,795
4 ALKS
Alkermes plc.
 2,814,804 $147,495,727
5 LNTH
Lantheus Holdings, Inc.
 1,013,063 $112,389,207
6 ELAN
Elanco Animal Health Inc
 2,676,050 $65,857,589
7 HLN
Haleon plc
 3,273,583 $30,542,527
8 XERS
Xeris Biopharma Holdings, Inc.
 2,365,103 $18,731,613

All Filings in AKBA

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $194,888 170,955
2026-03-31 $983,764 707,745
2025-12-31 $1,266,206 786,465
2025-09-30 $2,374,563 869,804
2025-06-30 $2,532,449 695,728
2025-03-31 $1,279,808 666,567
2024-12-31 $954,040 502,127
2024-09-30 $534,227 404,718
2022-03-31 $227,506 316,863
2021-12-31 $709,779 314,062
2021-06-30 $40,692,694 10,736,859
2021-03-31 $36,687,187 10,838,165
2020-12-31 $35,253,295 12,590,463
2020-09-30 $19,891,678 7,924,972
2020-06-30 $98,790,736 7,274,723
2020-03-31 $13,079,600 1,725,541